MHMustapha El Hamriti

Mustapha El Hamriti

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Mustapha El Hamriti has a total of 94 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Effects of Atrial Fibrillation Ablation on Arrhythmia Burden and Ventricular Function in End-Stage Heart Failure: Lessons from CASTLE-HTx

    by Vanessa Sciacca, Christian Sohns, Harry J.G.M. Crijns, Nassir F. Marrouche, Rene Schramm, Maximilian Moersdorf, Thomas Fink, Leonard Bergau, Gerhard Hindricks, Nikolaos Dagres, et al.

    Aims: The CASTLE-HTx trial showed the benefit of atrial fibrillation (AF) ablation compared to medical therapy in decreasing mortality, need for left ventricular assist device implantation or heart transplantation (HTx) in patients with end-stage heart failure (HF). Herein we describe the effects of catheter ablation on AF burden, arrhythmia recurrences, and ventricular function in end-stage HF. Methods and results: The CASTLE-HTx protocol randomized 194 patients in end-stage HF with AF to catheter ablation and medical therapy or medical therapy alone. AF burden, left ventricular ejection fraction (LVEF), and type of AF were assessed at baseline and at each follow-up visit. Overall, 97 patients received ablation; 66 patients (68%) underwent pulmonary vein isolation (PVI) and 31 patients (32%) were treated with PVI and additional ablation. Electroanatomic mapping showed the extent of left atrial low voltage (cardiomyopathy) >10% in 31 (31.9%) patients. At 12 months post-ablation, persistent AF was present in 31/89 patients (34.8%), which was significantly less frequent compared to baseline (p = 0.0001). Median AF burden reduction was 36.3 (interquartile range 13.6–63.3) percentage points at 12 months and LVEF improved from 29.2 ± 6.2% to 39.1 ± 8.3% (p < 0.001) following ablation. AF burden reduction <50% was significantly associated with LVEF improvement ≥5% at 12 months after ablation (p = 0.017). Conclusion: Atrial fibrillation ablation in end-stage HF leads to a substantial decrease in AF burden, a regression from persistent to paroxysmal AF and notably improved LVEF. Favourable ablation outcomes were observed in patients regardless of the presence or absence of signs indicating left atrial cardiomyopathy.


  • Open Access

    Enhancing origin prediction: deep learning model for diagnosing premature ventricular contractions with dual-rhythm analysis focused on cardiac rotation

    by Kazutaka Nakasone, Makoto Nishimori, Masakazu Shinohara, Mitsuru Takami, Kimitake Imamura, Taku Nishida, Akira Shimane, Yasushi Oginosawa, Yuki Nakamura, Yasuteru Yamauchi, et al.

    Aims: Several algorithms can differentiate inferior axis premature ventricular contractions (PVCs) originating from the right side and left side on 12-lead electrocardiograms (ECGs). However, it is unclear whether distinguishing the origin should rely solely on PVC or incorporate sinus rhythm (SR). We compared the dual-rhythm model (incorporating both SR and PVC) to the PVC model (using PVC alone) and quantified the contribution of each ECG lead in predicting the PVC origin for each cardiac rotation. Methods and results: This multicentre study enrolled 593 patients from 11 centres—493 from Japan and Germany, and 100 from Belgium, which were used as the external validation data set. Using a hybrid approach combining a Resnet50-based convolutional neural network and a transformer model, we developed two variants—the PVC and dual-rhythm models—to predict PVC origin. In the external validation data set, the dual-rhythm model outperformed the PVC model in accuracy (0.84 vs. 0.74, respectively; P < 0.01), precision (0.73 vs. 0.55, respectively; P < 0.01), specificity (0.87 vs. 0.68, respectively; P < 0.01), area under the receiver operating characteristic curve (0.91 vs. 0.86, respectively; P = 0.03), and F1-score (0.77 vs. 0.68, respectively; P = 0.03). The contributions to PVC origin prediction were 77.3% for PVC and 22.7% for the SR. However, in patients with counterclockwise rotation, SR had a greater contribution in predicting the origin of right-sided PVC. Conclusion: Our deep learning–based model, incorporating both PVC and SR morphologies, resulted in a higher prediction accuracy for PVC origin, considering SR is particularly important for predicting right-sided origin in patients with counterclockwise rotation.


  • Open Access

    Turning the corner in a one-stop-shop: protected ventricular tachycardia ablation and pulmonary vein isolation in late-stage heart failure

    by Stephan Winnik, Martin Braun, Mustapha El Hamriti, Christian Sohns

    An 82-year-old patient with end-stage heart failure secondary to ischaemic cardiomyopathy and ventricular arrhythmias was referred to our centre for management of recurrent electrical storm. The patient experienced multiple ventricular fibrillation episodes that were triggered by non-sustained ventricular arrhythmias related to myocardial scar and rapidly conducted atrial fibrillation (AF). The patient required repetitive cardiopulmonary resuscitation and multiple defibrillations despite intensive medical antiarrhythmic treatment. Progression of his coronary artery disease with history of coronary artery bypass graft surgery was ruled out by coronary angiography; the left ventricular ejection fraction was 20%.

  • Open Access

    Effects of hemodynamic support on arrhythmia-free survival following catheter ablation of ventricular arrhythmias

    by D Guckel, V Nesapiragasan, M El Hamriti, T Fink, V Sciacca, G Imnadze, M Khalaph, P Sommer, C Sohns

    Background: Radiofrequency-guided catheter ablation is an established therapy for ventricular tachycardia (VA). Hemodynamic support (HS) is often required for patients suffering from incessant VA to guide ablation. Data on the outcome of patients receiving HS during VA ablation procedures are lacking. Purpose: The aim of this observational study was to analyze the acute procedural success as well as long-term 36-month-VA-recurrence rates and mortality in patients requiring HS during VA ablation procedures. Methods: Data from consecutive patients receiving HS during VA ablation procedures between 2015-2023 were analyzed. HS was defined as the use of an Impella, an extracorporeal membrane oxygenation (ECMO) or a left ventricular assist device (LVAD). HS-group patients were compared to patients that underwent VA ablation procedures without HS. All patients were continuously followed up in our outpatient clinic. Data on procedural parameters, acute success and complications as well as long-term VA-free survival and mortality were analyzed. Results: A total of 95 consecutive patients (mean age 60.9 ± 11.0 years, 15% female) were included. 62 patients (65%, mean age 60.4±9.4 years, 16% female) receiving HS (ECMO or Impella: n=26, 42%; ECMO+Impella: n=7, 11%; LVAD: n=29, 47%) were compared to those without (mean age 61.7±13.5 years, 12 % female). In the HS-cohort a significantly lower left ventricular ejection fraction (LVEF) (p<0.001), a higher New York Heart Association (NYHA) functional class (p=0.013) and a more frequent antiarrhythmic drug use (p=0.045) was documented. Fluoroscopy times were significantly longer in the HS-group (HS: 10:22 ± 07:04 vs. no HS: 05:52 ± 02:50 minutes, p<0.001). Acute procedural success (HS: n=59, 95% vs. no HS: n=33, 100%, p=0.549) and major procedure complications (HS: n=4. 6% vs. no HS: n=4. 6%, p=1.000) were comparable between the two groups. Nevertheless, patients receiving HS had a significantly higher in-hospital mortality (HS: n=20, 32 % vs. no HS: n=2, 6%, p=0.004). The estimated 36-month-VA-free survival was comparable between the groups (Log-rank p=0.114). But Kaplan-Meier-plot analyses revealed a significantly higher estimated mortality in patients receiving HS (Log-rank p=0.002) (Figure 1). Between the subgroups (ECMO or Impella vs. LVAD) no statistically relevant differences were observed (Log-rank p=0.466). Multivariate analyses revealed HS as an independent predictor for mortality (Hazard ratio (HR) 3.259, Confidence Interval (CI) 1.060-10.015, p=0.039), but not for VA-recurrence. Conclusion: In the specific cohort of patients receiving HS, VA ablation procedures seem to be safe and effective with comparable acute and long-term success- and complication-rates. The need for HS seems to be associated with an increased risk for mortality. Further studies are required to validate our initial observations.Kaplan-Meier-plot on 36-month survival

  • Open Access

    Atrial fibrillation ablation workflow optimization facilitated by high-power short-duration ablation and high-resolution mapping

    by Thomas Fink, Vanessa Sciacca, Flemming Nischik, Leonard Bergau, Denise Guckel, Mustapha El Hamriti, Moneeb Khalaph, Martin Braun, Stephan Winnik, Maxim Didenko, et al.

    Pulmonary vein isolation (PVI) for catheter ablation of atrial fibrillation (AF) is a time-demanding procedure. High-power short-duration (HPSD) ablation protocols and high-density mapping catheters have recently been introduced to clinical practice. We investigated the impact of high-density mapping and HPSD ablation protocols on procedural timing, efficacy, and safety by comparing different standardized set-ups. Three electrophysiology (EP) laboratory set-ups were analysed: (i) circular catheter for mapping and HPSD ablation with 30/35 W guided by an ablation index (AI); (ii) pentaspline catheter for mapping an HPSD ablation with 50 W guided by an AI; and (iii) pentaspline catheter for mapping and HPSD ablation with 90 W over 4 s using a novel ablation catheter. All patients underwent PVI without additional left atrial ablation strategies. Procedural data and operating intervals in the EP laboratory were systematically analysed. Three hundred seven patients were analysed (30/35 W AI: n = 102, 50 W AI: n = 102, 90 W/4 s: n = 103). Skin-to-skin times [105.3 ± 22.7 (30/35 W AI) vs. 81.4 ± 21.3 (50 W AI) vs. 69.5 ± 12.2 (90 W/4 s) min, P ≤ 0.001] and total laboratory times (132.8 ± 42.1 vs. 107.4 ± 25.7 vs. 95.2 ± 14.0 min, P < 0.001) significantly differed among the study groups. Laboratory interval analysis revealed significant shortening of mapping and ablation times. Arrhythmia-free survival after 12 months was not different among the study groups (log-rank P = 0.96). The integration of high-density mapping and HPSD protocols into an institutional AF ablation process resulted in reduced procedure times without compromising safety or efficacy.


  • Open Access

    Successful ablation of Purkinje ectopy–triggered ventricular fibrillation storm in a patient with orthotopic heart transplantation and severe SARS-CoV-2 pneumonia: a case report

    by Moneeb Khalaph, Angelika Costard-Jäckle, Martin Braun, Mustapha El Hamriti

    Background: Catheter ablation is one of the most effective treatment options for patients with drug-refractory, scar-related monomorphic ventricular tachycardia (VT). In selected cases, catheter ablation also plays an important role in treatment of polymorphic VT (PMVT) and/or ventricular fibrillation (VF). Rarely, premature ventricular contractions (PVCs) originating from the Purkinje network can induce PMVT/VF. Ablation and elimination of these PVCs can prevent VF recurrences. Case summary: A 41-year-old patient with a history of orthotopic heart transplantation (HTX) 8 years before admission and newly diagnosed SARS-CoV-2 pneumonia was referred to our centre after experiencing several episodes of drug-refractory VF. An electrophysiological study showed ectopy-triggered VF originating from the anterior and posterior fascicles of the left bundle branch (LBB). Ablation of these PVCs from the LBB led to complete elimination of VF. A subcutaneous implantable cardioverter defibrillator was implanted as secondary prophylaxis. During the observation period of 6 months, no VF recurrence was observed. Conclusion: Identifying and eliminating the trigger (PVCs) can be life-saving and prevent VF in the specific cohort of HTX patients. High-density mapping using multipolar catheters with microelectrodes contributes significantly to our understanding of tachycardia mechanisms.


  • Open Access

    Successful ablation of ventricular fibrillation storm triggered by premature ventricular constructions after reperfusion of septal scar: let sleeping dogs lie

    by Moneeb Khalaph, Maxim Didenko, Mustapha El Hamriti, Christian Sohns

    Ventricular fibrillation (VF) storm, characterized by recurrent and sustained episodes of VF, poses a significant challenge in managing patients with underlying structural heart disease. This case highlights the successful management of VF storm triggered by PVCs after reperfusion of a septal scar through targeted ablation. Identification of the PVC focus within the scar tissue and precise mapping allowed for the effective elimination of the arrhythmogenic substrate. This case emphasizes the importance of an individualized approach combining catheter ablation techniques and advanced mapping technologies to achieve optimal outcomes in patients with complex arrhythmias.


  • Open Access

    Novel technique for significant reduction of phrenic nerve injury in cryoballoon pulmonary vein isolation

    by K Phkhaladze, H Omran, J Thale, V Sciacca, T Fink, K Isgandarova, M Braun, M Khalaph, D Guckel, M El Hamriti, et al.

    Background/Introduction: Pulmonary vein isolation (PVI) in cryoballoon (CB) technique is a golden standard for AF treatment. However, collateral damage of non-cardiac structures, such as phrenic nerve injury (PNI) remains an Achille’s heel of CB technology. Purpose: The purpose of this study was to develop a therapeutic concept while establishing a new technique with three consecutive steps during the procedure in order to significantly decrease the occurrence of PNI in the intervention group in comparison with control group. Methods: We conducted a retrospective, multicenter, observational review involving 1000 patients with symptomatic, treatment-resistant atrial fibrillation (AF) within last 8 years evaluating incidence and clinical characteristics of PNI during cryoballoon PVI. Patients were divided into the control (n=750) and intervention (n=250) groups. Patients in the intervention group were treated according to the new technique with three additional consecutive steps: A-Phrenic nerve stimulation close to the stimulation threshold (double output) instead of 10V stimulation. B-Advance approach for right superior pulmonary vein (PV) using the pre-freezing technique. C-Pull away after vein isolation and/or after achieving -40°C for both right-sided PVs. Results: A total of 1000 patients with a mean age of 63 (±11) years (62.3 % male) were investigated. 59.5% (n=595) of patients were admitted with paroxysmal AF, while 40.3% (n=403) suffered from persistent and 0.2% (n=2) from permanent AF. In 95.8% (958) it was the first PVI procedure. Two subtypes of PNI including permanent (without recovery until discharge) and transient (recovery until discharge) PNI were investigated. Transient PNI occurred in 8 patients (3.2%) in the intervention group compared to 46 patients (6.1%) in the control group, p=0.07. Persistent PNI occurred in one patient (0.4%) in the intervention group compared to 23 (3.1%) in the control group, p=0.017. Any PNI occurred in 9 patients in the intervention group (3.6%) compared to 69 patients (9.2%) in the control group, p=0.004. Conclusion: This retrospective study provides insights into the use and effectiveness of our novel technique for PVI, which could markedly reduce the incidence of PNI, especially persistent PNI.

  • Abstract 15076: Long-Term Recurrence Free Survival in Second Generation Cryoballoon Ablation for Persistent Atrial Fibrillation: It’s All About the Autonomic Nervous System

    by Denise Guckel, Mustapha El Hamriti, Thomas Fink, Vanessa Sciacca, Guram Imnadze, Martin Braun, Moneeb Khalaph, Khuraman Isgandarova, Philipp Sommer, Christian Sohns, et al.

  • Open Access

    Impact of the individual relationship between focal or rotational regions of interest and atrial cardiomyopathy in patients with chronic forms of atrial fibrillation

    by D Guckel, K Kramer, L Bergau, M Piran, M El Hamriti, T Fink, V Sciacca, H Koerperich, K Isgandarova, M Khalaph, et al.

    Funding Acknowledgements: Type of funding sources: None. Background: The mechanisms for the initiation and perpetuation of atrial fibrillation (AF) are still not completely understood. The CARTOFINDER module represents a novel approach for the visualisation of repetitive focal and rotational activations in patients with AF. Purpose: The aim of this prospective observational study was to evaluate the potential relationship between findings from CARTOFINDER mapping and individual atrial arrhythmia substrates. Beyond that, the impact of atrial fibrosis on patients’ outcome was analysed. Methods: A total of 20 consecutive patients (69 ± 9 years, 55 % male) underwent ablation for persistent AF (PERS) applying a 3D-mapping system with the integrated CARTOFINDER module. Regions of interest (ROIs) were identified before ablation. The individual amount and distribution of atrial fibrosis in the left atrium (LA) based on anatomical segments was determined by LGE CMR prior to the ablation procedure. 3, 6 and 12 month-follow-up data were assessed. Results: In all patients, ablation procedures were performed successfully (n=20, 100%). LA mapping time was 09.30 ± 03.53 min, mean ablation duration was 26.40 ± 07.51 mi, mean fluoroscopy time amounted to 6.66 ± 1.85 min. Consistent with Utah classes II-III, LGE-CMR revealed an intermediate degree of 21.41 ± 6.16% LA fibrosis. Focal and rotational ROIs were identified in all patients (mean no ROIs per Patient n = 416.45 ± 204.57). Univariate logistic regression calculation documented no consistent correlation between the percentage of LA fibrosis and the probability for the occurrence of ROIs (posterior: regression coefficient (b) =0.36, p-value (p) =0.24; anterior: b=-0.08, p=0.54; lateral: b=0.31, p=0,39; septal:b=-0.12; p=0.66; right PVs: b=0.34, p=0.27; left PVs: b=0.07, p=0.79; LAA: -0.91, p=0.11). Between the degree of atrial cardiomyopathy and the number of ROIs no association was observed (b=10.86, p=0.15). 12 months AF-free survival amounted to 70% (n=14). The degree of LA fibrosis showed no significant correlation with AF-free survival (logistic regression: posterior: b=0.33, p=0.12; anterior: b=-0.03, p=0.83; lateral: b=0.31, p=0,35; septal:b=-0.07; p=0.79; right PVs: b=0.81, p=0.15; left PVs: b=0.37, p=0.25; LAA: -0.16, p=0.54). Conclusions: This study reports on initial observations concerning the relationship between focal and rotational activations and atrial fibrosis in PERS AF. No evidence for a consistent correlation between the occurrence or number of ROIs and the degree of atrial arrhythmia substrates was revealed. Beyond that, the amount of LA fibrosis did not correlate with the 12 months AF-free survival rate. Larger studies are warranted to verify our first results.